Ardelyx Inc. (ARDX): Board Member Purchases Shares for Nearly $1 Million for the 3rd Consecutive Month!
Reading Time: 2 minutes
Ardelyx Inc. (ARDX) is a biopharmaceutical company that specializes in the development and marketing of therapies for gastrointestinal and cardiovascular diseases. In its pipeline are IBSRELA and XPHOZAH. IBSRELA is a medication for the treatment of irritable bowel syndrome with constipation (IBS-C). This is a condition where patients suffer from persistent constipation and abdominal pain. The medication acts directly in the intestines and alters how sodium is absorbed. This makes the stool softer, facilitating digestion and relieving abdominal...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
